Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Humana
(NY:
HUM
)
305.90
-5.51 (-1.77%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Humana
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
April 01, 2024
Via
Benzinga
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
March 31, 2024
Over the past 12 months, 10 Large-Cap stocks have underperformed all others.
Via
Talk Markets
10 Big-Name Stocks Near 52 Week Lows: Are They A Buy?
March 29, 2024
Over the past twelve months, a number of big-name companies have been near or below their 52-week low price. Each week we’ll take a look at some of the biggest names currently close to their 52-week...
Via
Talk Markets
Bitcoin Vs. Gold Vs. SPY: Which Asset Class Would've Given Best Returns On $1000 Investment In Q1?
March 29, 2024
The first quarter of 2024 has turned out to be a blockbuster for most asset classes, and the strong performances have left investors worried about the sustainability of the uptrend.
Via
Benzinga
Here's How Much $100 Invested In Humana 10 Years Ago Would Be Worth Today
March 26, 2024
Via
Benzinga
Decoding 15 Analyst Evaluations For Humana
March 22, 2024
Via
Benzinga
Olympic Behavioral Health Achieves Tricare Certification to Serve Military Families with High-Quality Addiction Treatment
March 28, 2024
Via
GetFeatured
Insurance Coverage For Weight Loss Drugs - Elevance, CVS Health Become First To Extend Coverage To Novo Nordisk's Successful Wegovy For Certain Patients
March 28, 2024
Major U.S. health insurers CVS Health, Elevance Health, and Kaiser Permanente now reimburse for Novo Nordisk's Wegovy for specific Medicare individuals with heart-related conditions. This shift aims to...
Via
Benzinga
Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business Contract
March 27, 2024
Walgreens Boots Alliance challenges a nearly $1 billion arbitration award issued to telemedicine provider PWNHealth, alleging excessive damages under contract terms. The dispute revolves around...
Via
Benzinga
Exposures
COVID-19
$100 Invested In Humana 15 Years Ago Would Be Worth This Much Today
March 18, 2024
Via
Benzinga
Critical Insights From Humana Analyst Ratings: What You Need To Know
March 06, 2024
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,100 Today
February 28, 2024
Via
Benzinga
Peering Into Humana's Recent Short Interest
February 16, 2024
Via
Benzinga
What Caused Humana’s Shocking Earnings Miss?
March 18, 2024
Humana missed estimates dramatically for the 4th quarter of last year and analysts have now cut their forecast for 2024 virtually in half.
Via
Talk Markets
Are These 3 Beaten-Down S&P 500 Members Worth A Look?
March 16, 2024
The performance of the S&P 500 has been weighed down by a few members, including Tesla, Humana, and Boeing. All three of these stocks have negatively impacted performance. Is this a buying opportunity,...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
The 3 Most Undervalued S&P 500 Stocks to Buy in March 2024
March 16, 2024
Investors looking to buy quality stocks on the dip should consider these names, each of which could turnaround in the long run.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
10 Big-Name Stocks Near 52-Week Lows: Are They A Buy?
March 16, 2024
Over the past twelve months a number of big named companies have been near or below their 52 week low price. Each week we’ll take a look at some of the biggest names currently close to their 52 week...
Via
Talk Markets
Old Dogs, New Tricks: 3 Dow Stocks Poised for a Comeback
March 15, 2024
These Dow stocks are world class companies that will overcome their recent challenges and soar to new highs.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Here's How Much You Would Have Made Owning Humana Stock In The Last 10 Years
February 13, 2024
Via
Benzinga
Behind the Scenes of Humana's Latest Options Trends
February 05, 2024
Via
Benzinga
Looking At Humana's Recent Unusual Options Activity
February 01, 2024
Via
Benzinga
Tesla And These Big Losers Are Far From Magnificent
March 10, 2024
Tesla isn't just 2024's worst performer in the Magnificent Seven.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
Via
Benzinga
Exit Now! 3 S&P 500 Stocks to Sell in February 2024
February 15, 2024
Steer clear of these companies that have problems that could worsen in the coming months, causing their share prices to fall further.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Nearly Half Of S&P 500 Stocks Trade Below 50-Day Moving Average: Which One Is The Cheapest?
February 14, 2024
Nearly half of S&P 500 stocks are below 50-day moving average, indicating poor market breadth. Only top 5 companies shielded from bearish pressures.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Looking Into Humana's Recent Short Interest
January 31, 2024
Via
Benzinga
3 Non-Tech Stocks With Significant Momentum Potential
February 14, 2024
Undervalued stocks are flying under the radar of investors. As such, we will highlight non-tech stocks with tremendous potential.
Via
InvestorPlace
What's Going On With Health Insurance Firm UnitedHealth Stock Today?
February 08, 2024
Explore UnitedHealth Group Inc stock insights! Discover recent market trends, CEO perspectives, and financial highlights.
Via
Benzinga
CVS Health's Q4 Earnings Relieve Investor Concerns But Lowers 2024 Profit Guidance Citing Elevated Medical Cost Trends
February 07, 2024
CVS Health beats Q4 expectations with $2.12 adjusted EPS, allays concerns over healthcare costs. Sales rise 11.9% to $93.81 billion.
Via
Benzinga
3 Sectors to Avoid Even in a Booming Economy
January 31, 2024
Even with the economy performing very well, some sectors are on the wrong side of powerful, ongoing trends. Here are three sectors to avoid.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.